002422 Sichuan Kelun Pharmaceutical
- 32.00
- +2.35+7.93%
Sichuan Kelun Pharmaceutical News
Colon Pharmaceutical: Announcement on the pledge and cancellation of the pledge of some of the shares of the controlling shareholder of the company
Colon Pharmaceuticals: Announcement on signing a fund-raising supervision agreement
Colon Pharmaceuticals: Verification Opinions on Using Some Idle Funds Raised to Temporarily Replenish Liquidity
Colon Pharmaceuticals: Deliberation Opinions at the Fourth Special Meeting of Independent Directors in 2024
Colon Pharmaceuticals: Announcement on Using Some Idle Funds Raised to Temporarily Replenish Liquidity
Colon Pharmaceuticals: Announcement of Resolutions of the Third Meeting of the Eighth Board of Supervisors
Colon Pharmaceuticals: Announcement on the use of letters of credit and own foreign exchange to pay for fund-raising project funds and replace them in equal amounts with the raised funds
Colon Pharmaceuticals: Announcement on the use of bank acceptance notes to pay funds for fund-raising projects and replace them in equal amounts with raised funds
Colon Pharmaceutical: Announcement of Resolutions of the Third Meeting of the Eighth Board of Directors
Colon Pharmaceuticals: Verification Opinions on Using Bank Acceptance Notes, Letters of Credit, and Own Foreign Exchange to Pay for Fund-raising Project Funds and Replace the Raised Funds in Equal Amounts
Colon Pharmaceutical: Announcement on the approval of didroprogesterone tablets for drug registration
Colon Pharmaceuticals: Announcement of Resolutions of the 2024 Second Extraordinary General Meeting of Shareholders
Colon Pharmaceuticals: Legal Opinion of Colon Pharmaceuticals 2024 Second Extraordinary General Meeting of Shareholders
Colon Pharmaceuticals: Announcement on the Return of Some Idle Raised Funds from Convertible Bonds to Temporarily Replenish Liquidity
Colon Pharmaceuticals: Announcement on the announcement of the subsidiary\'s core product, lukansastuzumab (sAC-TMT), at the 2024 European Society of Medical Oncology Conference
Colon Pharmaceuticals: Investor Relations Activity Record Form for August 29, 2024
Colon Pharmaceutical: Semi-annual Non-Operating Capital Occupancy and Other Related Capital Transactions Summary
Colon Pharmaceuticals: Notice on Convening the Second Extraordinary General Meeting of Shareholders in 2024
Colon Pharmaceuticals: Announcement on changes in the company\'s registered capital and amendments to the company\'s articles of association
Colon Pharmaceutical: “Constitution of Sichuan Colon Pharmaceutical Co., Ltd.” (August 2024)
Analysis
Price Target
No Data
No Data